FDA — authorised 29 March 2001
- Marketing authorisation holder: HOFFMANN LA ROCHE
- Status: approved
🇺🇸 Valcyte in United States
FDA authorised Valcyte on 29 March 2001
Marketing authorisation
Valcyte in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Valcyte approved in United States?
Yes. FDA authorised it on 29 March 2001.
Who is the marketing authorisation holder for Valcyte in United States?
HOFFMANN LA ROCHE holds the US marketing authorisation.